Sareum Holdings (SAR)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

38.00p
   
  • Change Today:
    -1.00p
  • 52 Week High: 135.00
  • 52 Week Low: 10.25
  • Currency: UK Pounds
  • Shares Issued: 106.84m
  • Volume: 445,316
  • Market Cap: £40.60m
  • RiskGrade: 594

Income Statement - Normalised

  £ (Millions) £ (Millions) £ (Millions) £ (Millions)
30-Jun-11 30-Jun-10 30-Jun-09 30-Jun-08
Continuing Operations        
Revenue n/a n/a n/a n/a
         
EBITDA (0.64) (0.64) (0.97) (1.63)
Depreciation & Amortisation n/a n/a (0.04) (0.39)
         
Operating Profit/(Loss) (0.64) (0.64) (1.00) (2.02)
Interest Payable n/a n/a 0.01 0.03
Interest Receivable/Investment Income 0.01 n/a n/a (0.04)
         
Group Profit after Interest (0.63) (0.64) (1.01) (2.94)
Share of Assoc Cos/JV Profits n/a n/a n/a n/a
         
Profit Before Tax (0.63) (0.64) (1.01) (2.94)
Tax 0.06 0.07 0.07 0.33
         
Profit After Tax (0.57) (0.57) (0.94) (2.61)
         
Discontinued Operations        
Profit After Tax n/a n/a 0.02 n/a
         
PROFIT FOR PERIOD (0.57) (0.57) (0.92) (1.69)
         
Attributable to:        
Equity Holders of Parent Company (0.57) (0.57) (0.92) (1.69)
Minority Interests n/a n/a n/a n/a
         
Equity Dividends cn/a cn/a cn/a cn/a
Retained Profit/(Loss) for the Financial Year c(0.57) c(0.57) c(0.92) c(1.69)


Per Share Record - Normalised 30-Jun-11 30-Jun-10 30-Jun-09 30-Jun-08
Continuing EPS        
Earnings per Share - Basic (0.042p) (0.052p) (0.12p) (0.44p)
Earnings per Share - Diluted (0.042p) (0.052p) (0.12p) (0.44p)
Earnings per Share - Adjusted (2.00p) (2.50p) (6.50p) (22.00p)
Continuing and Discontinued EPS        
Earnings per Share - Basic (0.042p) (0.052p) (0.11p) (0.28p)
Earnings per Share - Diluted (0.042p) (0.052p) (0.11p) (0.28p)
Earnings per Share - Adjusted (2.00p) (2.50p) (6.50p) (14.00p)
         
Dividend per Share n/a n/a n/a n/a


Key Financals 30-Jun-11 30-Jun-10 30-Jun-09 30-Jun-08
Shares in Issue (millions)        
Shares in Issue - Year End 1,450.60 1,175.60 818.10 818.10
Weighted Average 1,348.89 1,086.23 818.10 598.11
Diluted 1,348.89 1,086.23 818.10 598.11
         
Performance Ratios        
Continuing Operations        
Operating Margin n/a n/a n/a n/a
Return on Capital Employed n/a n/a n/a n/a
Continuing Operations & Discontinued Operations        
Return on Equity (64.86%) (108.79%) (282.03%) (120.82%)
         
Financial Status        
Continuing Operations        
Interest Cover - Continuing n/a n/a 72.83 90.15
Revenue per Share n/a n/a n/a n/a
Pre-Tax Profit Per Share - Continuing (0.047p) (0.059p) (0.12p) (0.49p)
         
Market Data        
Continuing Operations        
Earnings Per Share Growth - Basic n/a n/a n/a n/a
Earnings Per Share Growth - Diluted n/a n/a n/a n/a
PE Ratio - Company Adjusted n/a n/a n/a n/a
PEG - Company Adjusted n/a n/a n/a n/a
Dividend Cover n/a n/a n/a n/a
Continuing Operations & Discontinued Operations        
Earnings per Share - Company Adjusted n/a n/a n/a n/a
Earnings per Share - Diluted n/a n/a n/a n/a
PE Ratio - Company Adjusted n/a n/a n/a n/a
PEG - Company Adjusted n/a n/a n/a n/a
Dividend Cover n/a n/a n/a n/a
         
Market Capitalisation £ (Millions) 986.41 146.95 132.94 83.86
Dividend per Share n/a n/a n/a n/a
Dividend Yield 0.0% 0.0% 0.0% 0.0%
Dividend per Share Growth n/a n/a n/a n/a

Key

* GAAP

a. Includes discontinued activities

b. Includes preference dividends

c. Not disclosed under IFRS

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: Forecast figures based on normalised accounts.

 

Top of Page